Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Never-Smokers Needed for Study of Molecular Risk Factors for Lung Cancer
Author
Howard (Jack) West, MD

Actually, it's some background information and your blood that's needed.

Memorial Sloan-Kettering is running an important trial that is trying to determine some of the molecular factors that lead some never-smokers to develop lung cancer while other never-smokers don't. The trial is just a one-time collection of information in a questionnaire, I believe about medical history and environmental exposures, and submission of two vials of blood. There is no cost to participants, with all packaging and mail expenses pre-paid, and the registration and additional information is online here.

MSKCC NS blood trial

This is an important and timely question, and the researchers at Memorial Sloan-Kettering have been among the most important leaders in developing our understanding of the biology of not only never-smoker lung cancer, but also of lung cancer in general. I strongly encourage any never-smoker with lung cancer to participate.

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora